Axial pharmaceutical properties of liposome in cancer therapy: Recent advances and perspectives

Int J Pharm. 2020 May 15:581:119269. doi: 10.1016/j.ijpharm.2020.119269. Epub 2020 Mar 28.

Abstract

Evaluation of axial properties including preparation, surface functionalization, and pharmacokinetics for delivery of pharmacologically active molecules and genes lead to pharmaceutical development of liposome in cancer therapy. Here, analysis of effects of the axial properties of liposome based on cancer treatment modalities as individually and coherently is vital and shows deserving further investigation for the future. In this review, recent progress in the analysis of preparation approaches, optimizing pharmacokinetic parameters, functionalization and targeting improvement and modulation of biological factors and components resulting in a better function of liposome in cancer for drug/gene delivery and immunotherapy are discussed. Here, recent developments on liposome with vaccines and immunoadjuvant carriers, and antigen-carrier system to cancer immunotherapy are introduced.

Keywords: Cancer Therapy; Cell Signaling Pathways and Gene Delivery; Functionalization and Targeting; Liposome; Pharmacokinetics; Preparation.

Publication types

  • Review

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Animals
  • Antineoplastic Agents / administration & dosage
  • Cancer Vaccines / administration & dosage
  • Disease Models, Animal
  • Drug Carriers / chemistry
  • Drug Carriers / pharmacology*
  • Drug Compounding / methods*
  • Gene Transfer Techniques*
  • Genetic Therapy / methods
  • Humans
  • Liposomes / chemistry
  • Liposomes / pharmacology*
  • Neoplasms / genetics
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Adjuvants, Immunologic
  • Antineoplastic Agents
  • Cancer Vaccines
  • Drug Carriers
  • Liposomes